MetaCap

Atossa Therapeutics Insider Trades

NASDAQ: ATOSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.44+0.02 (+0.83%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Atossa Therapeutics insider activity

Over the last 12 months, Atossa Therapeutics insiders reported 10 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Steinhart Richard I (Director) reporting a transaction in 10,000 shares on May 12, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ATOS's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ATOS insider transactions

Atossa Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
May 12, 2026Cigler TessaDirectorAward10,000—Form 4
May 12, 2026Galli Stephen JDirectorAward10,000—Form 4
May 12, 2026Finn JonathanDirectorAward10,000—Form 4
May 12, 2026Remmel H. LawrenceDirectorAward10,000—Form 4
May 12, 2026Chen Shu-ChihDirectorAward10,000—Form 4
May 12, 2026Steinhart Richard IDirectorAward10,000—Form 4
Mar 27, 2026QUAY STEVEN CPresident & CEOAward65,000—Form 4
Mar 26, 2026Daniel Mark JamesChief Financial OfficerAward63,000—Form 4
Jan 20, 2026QUAY STEVEN CPresident & CEOAward325,203—Form 4
Jan 20, 2026QUAY STEVEN CPresident & CEOAward331,674—Form 4
May 21, 2025QUAY STEVEN CPresident & CEOBuy11,239$9.89KForm 4
Mar 26, 2025Remmel H. LawrenceDirectorBuy10,000$7.00KForm 4
Apr 10, 2024Finn JonathanDirectorBuy25,000$44.25KForm 4
Nov 15, 2023WEAVER GREGORY LFormer EVP, CFO, & DirectorSale50,000$32.50KForm 4
Jun 20, 2023WEAVER GREGORY LEVP & CFOBuy50,000$48.50KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related